PubMed:9191057
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 10-18 | protein | denotes | cyclin A |
| T2 | 72-99 | cell_type | denotes | human primary T lymphocytes |
| T3 | 104-107 | protein | denotes | CD2 |
| T4 | 112-116 | protein | denotes | CD28 |
| T5 | 117-135 | protein | denotes | adhesion molecules |
| T6 | 137-145 | protein | denotes | Cyclin A |
| T7 | 366-374 | protein | denotes | Cyclin A |
| T8 | 384-405 | cell_type | denotes | primary T lymphocytes |
| T9 | 465-486 | protein | denotes | monoclonal antibodies |
| T10 | 499-502 | protein | denotes | CD2 |
| T11 | 507-511 | protein | denotes | CD28 |
| T12 | 512-530 | protein | denotes | adhesion molecules |
| T13 | 592-607 | cell_type | denotes | accessory cells |
| T14 | 609-617 | protein | denotes | Cyclin A |
| T15 | 666-674 | protein | denotes | anti CD2 |
| T16 | 677-681 | protein | denotes | CD28 |
| T17 | 705-713 | protein | denotes | anti CD2 |
| T18 | 717-726 | protein | denotes | anti CD28 |
| T19 | 816-846 | DNA | denotes | transcription initiation sites |
| T20 | 879-900 | DNA | denotes | protein binding sites |
| T21 | 977-982 | protein | denotes | ATF-1 |
| T22 | 987-1000 | protein | denotes | NF-Y proteins |
| T23 | 1075-1083 | protein | denotes | anti CD2 |
| T24 | 1087-1096 | protein | denotes | anti CD28 |
| T25 | 1133-1141 | protein | denotes | anti CD2 |
| T26 | 1144-1153 | protein | denotes | anti CD28 |
| T27 | 1393-1401 | protein | denotes | anti CD2 |
| T28 | 1404-1413 | protein | denotes | anti CD28 |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-136 | Sentence | denotes | Relief of cyclin A gene transcriptional inhibition during activation of human primary T lymphocytes via CD2 and CD28 adhesion molecules. |
| S2 | 137-226 | Sentence | denotes | Cyclin A transcription is cell cycle regulated and induced by cell proliferative signals. |
| S3 | 227-406 | Sentence | denotes | To understand the mechanisms underlined in this regulation in normal human cells, we have analysed in vivo protein-DNA interactions at the Cyclin A locus in primary T lymphocytes. |
| S4 | 407-608 | Sentence | denotes | Stimulation of purified T lymphocytes by a combination of monoclonal antibodies directed at CD2 and CD28 adhesion molecules gives rise to a long lasting proliferation in the absence of accessory cells. |
| S5 | 609-751 | Sentence | denotes | Cyclin A was observed after 4 days of costimulation with anti CD2 + CD28 whereas stimulation by anti CD2 or anti CD28 alone was not effective. |
| S6 | 752-944 | Sentence | denotes | In vivo genomic DMS footprinting revealed upstream of the major transcription initiation sites, the presence of at least three protein binding sites, two of which were constitutively occupied. |
| S7 | 945-1001 | Sentence | denotes | They bind in vitro respectively ATF-1 and NF-Y proteins. |
| S8 | 1002-1103 | Sentence | denotes | The third site was occupied in quiescent cells or in cells stimulated by anti CD2 or anti CD28 alone. |
| S9 | 1104-1218 | Sentence | denotes | The mitogenic combination of anti CD2 + anti CD28 released the footprint as cells were committed to proliferation. |
| S10 | 1219-1472 | Sentence | denotes | Consistent with theses results, nuclear extracts prepared from quiescent cells formed a specific complex with this element, whereas extracts prepared from cells treated with anti CD2 + anti CD28 failed to do so after cells entered a proliferative state. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 72-99 | NP | denotes | human primary T lymphocytes |
| C2 | 104-135 | NP | denotes | CD2 and CD28 adhesion molecules |
| C3 | 384-405 | NP | denotes | primary T lymphocytes |
| C4 | 499-530 | NP | denotes | CD2 and CD28 adhesion molecules |
| C5 | 666-681 | NP | denotes | anti CD2 + CD28 |
| C7 | 705-713 | NP | denotes | anti CD2 |
| C8 | 717-726 | NP | denotes | anti CD28 |
| C6 | 705-732 | NP | denotes | anti CD2 or anti CD28 alone |
| C9 | 864-900 | NP | denotes | at least three protein binding sites |
| C12 | 902-905 | NP | denotes | two |
| C13 | 909-914 | NP | denotes | which |
| C11 | 902-914 | NP | denotes | two of which |
| C10 | 902-943 | NP | denotes | two of which were constitutively occupied |
| C14 | 945-949 | NP | denotes | They |
| C15 | 1002-1016 | NP | denotes | The third site |
| C16 | 1033-1048 | NP | denotes | quiescent cells |
| C18 | 1075-1083 | NP | denotes | anti CD2 |
| C19 | 1087-1096 | NP | denotes | anti CD28 |
| C17 | 1075-1102 | NP | denotes | anti CD2 or anti CD28 alone |
| C21 | 1133-1153 | NP | denotes | anti CD2 + anti CD28 |
| C20 | 1104-1153 | NP | denotes | The mitogenic combination of anti CD2 + anti CD28 |
| C22 | 1282-1297 | NP | denotes | quiescent cells |
| C23 | 1329-1341 | NP | denotes | this element |
| C24 | 1393-1413 | NP | denotes | anti CD2 + anti CD28 |
| R1 | C3 | C1 | coref-ident | primary T lymphocytes,human primary T lymphocytes |
| R2 | C4 | C2 | coref-ident | CD2 and CD28 adhesion molecules,CD2 and CD28 adhesion molecules |
| R3 | C13 | C12 | coref-relat | which,two |
| R4 | C11 | C9 | coref-ident | two of which,at least three protein binding sites |
| R5 | C14 | C10 | coref-pron | They,two of which were constitutively occupied |
| R6 | C15 | C9 | coref-ident | The third site,at least three protein binding sites |
| R7 | C18 | C7 | coref-ident | anti CD2,anti CD2 |
| R8 | C19 | C8 | coref-ident | anti CD28,anti CD28 |
| R9 | C17 | C6 | coref-ident | anti CD2 or anti CD28 alone,anti CD2 or anti CD28 alone |
| R10 | C21 | C5 | coref-ident | anti CD2 + anti CD28,anti CD2 + CD28 |
| R11 | C22 | C16 | coref-ident | quiescent cells,quiescent cells |
| R12 | C23 | C20 | coref-ident | this element,The mitogenic combination of anti CD2 + anti CD28 |
| R13 | C24 | C21 | coref-ident | anti CD2 + anti CD28,anti CD2 + anti CD28 |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 10-18 | protein_molecule | denotes | cyclin A |
| T2 | 72-99 | cell_type | denotes | human primary T lymphocytes |
| T3 | 104-107 | protein_molecule | denotes | CD2 |
| T4 | 112-116 | protein_molecule | denotes | CD28 |
| T5 | 117-135 | protein_family_or_group | denotes | adhesion molecules |
| T6 | 137-145 | protein_molecule | denotes | Cyclin A |
| T7 | 199-225 | other_name | denotes | cell proliferative signals |
| T8 | 334-358 | other_name | denotes | protein-DNA interactions |
| T9 | 366-374 | protein_molecule | denotes | Cyclin A |
| T10 | 384-405 | cell_type | denotes | primary T lymphocytes |
| T11 | 465-486 | protein_family_or_group | denotes | monoclonal antibodies |
| T12 | 499-502 | protein_molecule | denotes | CD2 |
| T13 | 507-511 | protein_molecule | denotes | CD28 |
| T14 | 512-530 | protein_family_or_group | denotes | adhesion molecules |
| T15 | 592-607 | cell_type | denotes | accessory cells |
| T16 | 609-617 | protein_molecule | denotes | Cyclin A |
| T17 | 666-670 | protein_family_or_group | denotes | anti |
| T18 | 671-674 | protein_molecule | denotes | CD2 |
| T19 | 677-681 | protein_molecule | denotes | CD28 |
| T20 | 705-709 | protein_family_or_group | denotes | anti |
| T21 | 710-713 | protein_molecule | denotes | CD2 |
| T22 | 717-721 | protein_family_or_group | denotes | anti |
| T23 | 722-726 | protein_molecule | denotes | CD28 |
| T24 | 752-784 | other_name | denotes | In vivo genomic DMS footprinting |
| T25 | 816-846 | DNA_domain_or_region | denotes | transcription initiation sites |
| T26 | 879-900 | DNA_domain_or_region | denotes | protein binding sites |
| T27 | 977-982 | protein_molecule | denotes | ATF-1 |
| T28 | 987-1000 | protein_molecule | denotes | NF-Y proteins |
| T29 | 1075-1079 | protein_family_or_group | denotes | anti |
| T30 | 1080-1083 | protein_molecule | denotes | CD2 |
| T31 | 1087-1091 | protein_family_or_group | denotes | anti |
| T32 | 1092-1096 | protein_molecule | denotes | CD28 |
| T33 | 1133-1137 | protein_family_or_group | denotes | anti |
| T34 | 1138-1141 | protein_molecule | denotes | CD2 |
| T35 | 1144-1148 | protein_family_or_group | denotes | anti |
| T36 | 1149-1153 | protein_molecule | denotes | CD28 |
| T37 | 1251-1267 | cell_component | denotes | nuclear extracts |
| T38 | 1393-1397 | protein_family_or_group | denotes | anti |
| T39 | 1398-1401 | protein_molecule | denotes | CD2 |
| T40 | 1404-1408 | protein_family_or_group | denotes | anti |
| T41 | 1409-1413 | protein_molecule | denotes | CD28 |
| T42 | 1452-1471 | other_name | denotes | proliferative state |